Learn More
Medchemexpress LLC Methyl N-[[(5S)-3-[3-fluoro-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl... | 2071265-08-0 | 99.7% | C17H20FN3O5 | 10MG

Supplier: Medchemexpress LLC HY13939810MG
TBI-223 is an orally active oxazolidinone-class antibiotic research compound showing activity against Mycobacterium tuberculosis and demonstrated efficacy in mouse infection models. It inhibits mitochondrial protein synthesis in HepG2 cells and is supplied as a solid with defined storage recommendations for long-term stability.
- Orally active oxazolidinone scaffold.
- Shows activity against Mycobacterium tuberculosis.
- Demonstrated efficacy in multiple mouse infection models.
- Inhibits mitochondrial protein synthesis in HepG2 cells (IC50 = 68 μg/mL).
- High purity and defined storage conditions for stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.